A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jackson Christopher, MD
Dunedin Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Monash Medical Centre
Clayton, Australia
- Auckland City Hospital
Auckland, New Zealand
- Dunedin Hospital
Dunedin, New Zealand
- Wellington Regional Hospital
Wellington, New Zealand
- Taipei Medical University Shuang Ho Hospital
New Taipei City, Taiwan
- Tri-Service General Hospital
Taipei, Taiwan
- Lotung Poh-Ai Hospital
Yilan, Taiwan
- the Christie Nhs Foundation Trust
Manchester, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Sept 2015
- Primary completion
- 15 Jun 2021
- Completion
- 15 Jun 2021
- Last update posted
- 29 Jul 2021
- Registered enrollment
- 44
- Registry id
- NCT04180384
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.